Medexus Pharmaceuticals Stock Price History
MDP Stock | 2.74 0.07 2.49% |
Below is the normalized historical share price chart for Medexus Pharmaceuticals extending back to January 09, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Medexus Pharmaceuticals stands at 2.74, as last reported on the 21st of July, with the highest price reaching 2.84 and the lowest price hitting 2.71 during the day.
If you're considering investing in Medexus Stock, it is important to understand the factors that can impact its price. Medexus Pharmaceuticals appears to be risky, given 3 months investment horizon. Medexus Pharmaceuticals has Sharpe Ratio of 0.0586, which conveys that the firm had a 0.0586 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Medexus Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Medexus Pharmaceuticals' Downside Deviation of 3.23, risk adjusted performance of 0.0911, and Mean Deviation of 2.65 to check out if our risk estimates are consistent with your expectations.
At this time, Medexus Pharmaceuticals' Total Stockholder Equity is very stable compared to the past year. As of the 21st of July 2025, Liabilities And Stockholders Equity is likely to grow to about 180.4 M, while Common Stock Shares Outstanding is likely to drop about 17.9 M. . At this time, Medexus Pharmaceuticals' Price To Sales Ratio is very stable compared to the past year. As of the 21st of July 2025, Price Sales Ratio is likely to grow to 1.63, while Price Earnings Ratio is likely to drop (1.81). Medexus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 2.8828 | 50 Day MA 2.9378 | Beta 2.044 |
Medexus |
Sharpe Ratio = 0.0586
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | MDP | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.36 actual daily | 30 70% of assets are more volatile |
Expected Return
0.2 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Medexus Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medexus Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 1.2698 | Enterprise Value Ebitda 4.7099 | Price Sales 0.8367 | Shares Float 29.9 M | Wall Street Target Price 6.4643 |
Medexus Pharmaceuticals Stock Price History Chart
There are several ways to analyze Medexus Stock price data. The simplest method is using a basic Medexus candlestick price chart, which shows Medexus Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | June 23, 2025 | 3.4 |
Lowest Price | May 14, 2025 | 2.5 |
Medexus Pharmaceuticals July 21, 2025 Stock Price Synopsis
Various analyses of Medexus Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Medexus Stock. It can be used to describe the percentage change in the price of Medexus Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Medexus Stock.Medexus Pharmaceuticals Price Rate Of Daily Change | 0.98 | |
Medexus Pharmaceuticals Price Daily Balance Of Power | (0.54) | |
Medexus Pharmaceuticals Accumulation Distribution | 2,195 | |
Medexus Pharmaceuticals Price Action Indicator | (0.07) |
Medexus Pharmaceuticals July 21, 2025 Stock Price Analysis
Medexus Stock Price History Data
The price series of Medexus Pharmaceuticals for the period between Tue, Apr 22, 2025 and Mon, Jul 21, 2025 has a statistical range of 1.05 with a coefficient of variation of 7.74. The daily prices for the period are spread out with arithmetic mean of 2.87. The median price for the last 90 days is 2.88. The company underwent 1:15 stock split on 19th of December 2018. Medexus Pharmaceuticals issued dividends to stockholders on 2018-12-19.Open | High | Low | Close | Volume | ||
07/21/2025 | 2.84 | 2.84 | 2.71 | 2.74 | 47,958 | |
07/18/2025 | 2.88 | 2.90 | 2.81 | 2.81 | 26,097 | |
07/17/2025 | 2.85 | 2.92 | 2.83 | 2.88 | 37,072 | |
07/16/2025 | 2.83 | 2.85 | 2.78 | 2.82 | 44,920 | |
07/15/2025 | 2.93 | 2.93 | 2.80 | 2.80 | 28,312 | |
07/14/2025 | 2.93 | 2.97 | 2.88 | 2.94 | 50,075 | |
07/11/2025 | 3.06 | 3.12 | 2.89 | 2.93 | 24,029 | |
07/10/2025 | 3.01 | 3.08 | 3.00 | 3.06 | 37,344 | |
07/09/2025 | 3.02 | 3.05 | 2.96 | 2.96 | 31,891 | |
07/08/2025 | 3.07 | 3.10 | 3.01 | 3.01 | 19,200 | |
07/07/2025 | 3.10 | 3.14 | 3.01 | 3.01 | 55,966 | |
07/04/2025 | 3.10 | 3.12 | 2.98 | 3.11 | 32,516 | |
07/03/2025 | 3.17 | 3.18 | 3.02 | 3.03 | 45,855 | |
07/02/2025 | 3.18 | 3.29 | 3.13 | 3.13 | 37,144 | |
06/30/2025 | 3.24 | 3.24 | 3.15 | 3.17 | 14,211 | |
06/27/2025 | 3.18 | 3.27 | 3.15 | 3.15 | 61,584 | |
06/26/2025 | 3.40 | 3.61 | 3.06 | 3.15 | 133,801 | |
06/25/2025 | 3.35 | 3.35 | 3.23 | 3.35 | 46,200 | |
06/24/2025 | 3.46 | 3.48 | 3.25 | 3.28 | 80,669 | |
06/23/2025 | 3.23 | 3.43 | 3.23 | 3.40 | 85,600 | |
06/20/2025 | 3.13 | 3.27 | 3.11 | 3.22 | 31,500 | |
06/19/2025 | 3.09 | 3.25 | 3.05 | 3.17 | 17,800 | |
06/18/2025 | 3.10 | 3.20 | 3.05 | 3.09 | 39,399 | |
06/17/2025 | 3.05 | 3.10 | 3.00 | 3.03 | 35,137 | |
06/16/2025 | 2.98 | 3.19 | 2.98 | 3.00 | 55,522 | |
06/13/2025 | 2.95 | 2.96 | 2.89 | 2.93 | 15,993 | |
06/12/2025 | 2.95 | 2.97 | 2.90 | 2.93 | 24,563 | |
06/11/2025 | 2.87 | 2.99 | 2.87 | 2.95 | 6,408 | |
06/10/2025 | 2.84 | 2.91 | 2.79 | 2.86 | 36,633 | |
06/09/2025 | 2.91 | 2.96 | 2.84 | 2.84 | 16,300 | |
06/06/2025 | 2.92 | 2.93 | 2.84 | 2.84 | 23,511 | |
06/05/2025 | 2.92 | 2.92 | 2.83 | 2.90 | 22,100 | |
06/04/2025 | 3.01 | 3.06 | 2.90 | 2.90 | 14,639 | |
06/03/2025 | 2.95 | 3.02 | 2.90 | 2.96 | 33,290 | |
06/02/2025 | 2.93 | 2.99 | 2.91 | 2.93 | 38,437 | |
05/30/2025 | 2.93 | 3.08 | 2.88 | 3.08 | 31,535 | |
05/29/2025 | 2.94 | 2.97 | 2.88 | 2.88 | 9,900 | |
05/28/2025 | 2.97 | 2.97 | 2.88 | 2.89 | 10,245 | |
05/27/2025 | 2.96 | 3.08 | 2.90 | 2.92 | 56,348 | |
05/26/2025 | 2.75 | 2.97 | 2.75 | 2.94 | 23,433 | |
05/23/2025 | 2.80 | 2.88 | 2.74 | 2.75 | 26,332 | |
05/22/2025 | 2.66 | 2.74 | 2.66 | 2.72 | 11,567 | |
05/21/2025 | 2.59 | 2.80 | 2.59 | 2.64 | 57,881 | |
05/20/2025 | 2.69 | 2.70 | 2.55 | 2.58 | 14,735 | |
05/16/2025 | 2.69 | 2.77 | 2.69 | 2.69 | 5,236 | |
05/15/2025 | 2.52 | 2.71 | 2.52 | 2.69 | 21,466 | |
05/14/2025 | 2.62 | 2.62 | 2.50 | 2.50 | 28,205 | |
05/13/2025 | 2.75 | 2.75 | 2.59 | 2.59 | 20,693 | |
05/12/2025 | 2.86 | 2.86 | 2.71 | 2.73 | 37,074 | |
05/09/2025 | 2.85 | 2.98 | 2.85 | 2.92 | 44,511 | |
05/08/2025 | 2.59 | 2.85 | 2.57 | 2.83 | 67,943 | |
05/07/2025 | 2.67 | 2.69 | 2.57 | 2.59 | 22,666 | |
05/06/2025 | 2.74 | 2.74 | 2.64 | 2.65 | 29,679 | |
05/05/2025 | 2.79 | 2.81 | 2.71 | 2.71 | 10,901 | |
05/02/2025 | 2.81 | 2.90 | 2.76 | 2.76 | 18,300 | |
05/01/2025 | 2.80 | 2.97 | 2.78 | 2.80 | 36,760 | |
04/30/2025 | 2.75 | 2.81 | 2.62 | 2.74 | 25,800 | |
04/29/2025 | 2.73 | 2.81 | 2.70 | 2.81 | 7,802 | |
04/28/2025 | 2.68 | 2.71 | 2.66 | 2.70 | 11,500 | |
04/25/2025 | 2.79 | 2.82 | 2.68 | 2.70 | 38,500 | |
04/24/2025 | 2.65 | 2.77 | 2.64 | 2.77 | 14,129 |
About Medexus Pharmaceuticals Stock history
Medexus Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Medexus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Medexus Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Medexus Pharmaceuticals stock prices may prove useful in developing a viable investing in Medexus Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 32.3 M | 17.9 M | |
Net Income Applicable To Common Shares | 2.2 M | 2.4 M |
Medexus Pharmaceuticals Stock Technical Analysis
Medexus Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
All Next | Launch Module |
Medexus Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Medexus Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Medexus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Medexus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0911 | |||
Jensen Alpha | 0.3409 | |||
Total Risk Alpha | (0.18) | |||
Sortino Ratio | 0.0523 | |||
Treynor Ratio | (0.96) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Other Information on Investing in Medexus Stock
Medexus Pharmaceuticals financial ratios help investors to determine whether Medexus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medexus with respect to the benefits of owning Medexus Pharmaceuticals security.